Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PREMIER) March 23, 2022https://clinicaltrials.gov/ct2/show/NCT04762758
A Study to Assess the Efficacy and Safety of PXT3003 in Charcot-Marie-Tooth Type 1A March 2, 2022https://clinicaltrials.gov/ct2/show/NCT05092841
